Evidence map›Paper›PMID 36348302›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2023

Biomarkers of alveolar epithelial injury and endothelial dysfunction are associated with scores of pulmonary edema in invasively ventilated patients.

Leila N Atmowihardjo, Nanon F L Heijnen, Marry R Smit, Laura A Hagens, Daan F L Filippini, Claudio Zimatore, Marcus J Schultz, Ronny M Schnabel, Dennis C J J Bergmans, Jurjan Aman and 2 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Research advances in consistency and variability inJournal of thoracic disease · 2026
    Review
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 5 countries.

Leila N AtmowihardjoIntensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-7452-1867
Nanon F L HeijnenIntensive Care, Maastricht University Medical Center+, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-9147-891X
Marry R SmitIntensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-9938-6035
Laura A HagensIntensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-4629-4465
Daan F L FilippiniIntensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Claudio ZimatoreIntensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-4875-4018
Marcus J SchultzIntensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Ronny M SchnabelIntensive Care, Maastricht University Medical Center+, Maastricht University, Maastricht, The Netherlands.
Dennis C J J BergmansIntensive Care, Maastricht University Medical Center+, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-4224-6426
Jurjan AmanDepartment of Pulmonology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Lieuwe D J BosIntensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-2911-4549
DARTS Consortium
Amsterdam University Medical Centers · NLMaastricht University · NLMahidol University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary edema is a central hallmark of acute respiratory distress syndrome (ARDS). Endothelial dysfunction and epithelial injury contribute to alveolar-capillary permeability but their differential contribution to pulmonary edema development remains understudied. Plasma levels of surfactant protein-D (SP-D), soluble receptor for advanced glycation end products (sRAGE), and angiopoietin-2 (Ang-2) were measured in a prospective, multicenter cohort of invasively ventilated patients. Pulmonary edema was quantified using the radiographic assessment of lung edema (RALE) and global lung ultrasound (LUS) score. Variables were collected within 48 h after intubation. Linear regression was used to examine the association of the biomarkers with pulmonary edema. In 362 patients, higher SP-D, sRAGE, and Ang-2 concentrations were significantly associated with higher RALE and global LUS scores. After stratification by ARDS subgroups (pulmonary, nonpulmonary, COVID, non-COVID), the positive association of SP-D levels with pulmonary edema remained, whereas sRAGE and Ang-2 showed less consistent associations throughout the subgroups. In a multivariable analysis, SP-D levels were most strongly associated with pulmonary edema when combined with sRAGE (RALE score: β

Indexed as

COVID-19Pulmonary EdemaRespiratory Distress SyndromeVascular DiseasesBiomarkersHumansProspective StudiesPulmonary Surfactant-Associated Protein DReceptor for Advanced Glycation End ProductsRespiration, ArtificialRespiratory SoundsBiomarkersPulmonary Surfactant-Associated Protein DReceptor for Advanced Glycation End ProductsARDSendothelial dysfunctionepithelial injurypulmonary edemavascular permeability

Identifiers

PMID36348302
PMCPMC9799153
OpenAlexW4308566773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.